Group Telehealth Behavioral Cough Suppression Therapy

Recruiting now · Early Phase 1

Conditions studied: Refractory Chronic Cough

In brief

The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.

Key facts

Study ID

NCT06706765

Run by

University of Montana

People needed

60

Starts

2024-03-22

Expected to finish

2025-01-31

Last updated by the study team

2024-11-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 18 years old
• Predominantly dry cough for at least 8 weeks
• Evaluated and treated by at least one physician for cough
• Obtained a chest X-ray or chest CT scan specifically related to the cough with unremarkable results
• Access to a computer or tablet that includes a camera and able to use the device independently
• Reliable internet access
• Willing to agree to maintain confidentiality of personal information (including names) related to others in the study

You may not qualify if…

• Under age 18
• Coughing up blood
• Current smoker of any substance
• History of smoking or 10 or more years
• Diagnosed with a chronic lung condition (e.g., COPD, emphysema, lung cancer, idiopathic pulmonary fibrosis, chronic bronchitis, asthma)? (NOTE: If a patient has been told their cough may be (or is likely) due to asthma but they have not had any formal lung testing and asthma treatments have not helped your cough, we don't consider this a formal asthma diagnosis and will not exclude them from the study.)
• Diagnosed currently or in the past with head and neck cancer (i.e., cancer of the mouth, nose, or throat).
• Complaints of swallowing difficulty
• Taking any of the following medications, which have a known side effect of cough: Benzapril (Lotensin), Captopril (Capoten), Enalapril/Enalaprilat (Vasotec oral and injectable), Fosinopril (Monopril), Lisinopril (Zestril and Prinivil), Moexipril (Univasc), Perindopril (Aceon), Quinapril (Accupril), Ramipril (Altace), and Trandolapril (Mavik)
• Prior BCST treatment with an SLP or respiratory therapist

Where it is running

• University of Montana — Missoula, Montana, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.